Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Polycythemia hypertonica revisited: a metabolic syndrome with high-renin hypertension?

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1
Fig. 2


  1. Hall CA. Gaisbock’s disease: redefinition of an old syndrome. Arch Intern Med. 1965;116:4–9.

    CAS  Article  Google Scholar 

  2. Emery AC Jr, Whitcomb WH, Frohlich ED. “Stress” polycythemia and hypertension. JAMA. 1974;229:159–62.

    Article  Google Scholar 

  3. Stefanini M, Urbas JV, Urbas JE. Gaisböck’s syndrome: its hematologic, biochemical and hormonal parameters. Angiology. 1978;29:520–33.

    CAS  Article  Google Scholar 

  4. El-Yousef MK, Bakewell WE Jr. Stress polycythemia—a pathophysiologic study. South Med J. 1975;68:559–64.

    CAS  Article  Google Scholar 

  5. Wang YY, Lin SY, Liu PH, Cheung BM, Lai WA. Association between hematological parameters and metabolic syndrome components in a Chinese population. J Diabetes Complications. 2004;18:322–7.

    Article  Google Scholar 

  6. Yu C, Xu C, Xu L, Yu J, Miao M, Li Y. Serum proteomic analysis revealed diagnostic value of haemoglobin for non-alcoholic fatty liver disease. J Hepatol. 2012;56:241–7.

    CAS  Article  Google Scholar 

  7. Krishnamoorthy P, Gopalakrishnan A, Mittal V, Kalla A, Slipczuk L, Rangaswami J, et al. Gaisböck syndrome (polycythemia and hypertension) revisited: results from the national inpatient sample database. J Hypertens. 2018;36:2420–4.

    CAS  Article  Google Scholar 

  8. Cabandugama PK, Gardner MJ, Sowers JR. The renin angiotensin aldosterone system in obesity and hypertension: roles in the Cardiorenal Metabolic Syndrome (CRS). Med Clin North Am. 2017;101:129–37.

    Article  Google Scholar 

  9. Tarazi RC, Frohlich ED, Dustan HP, Gifford Jr RW, Page IH. Hypertension and high hematocrit: another clue to renal arterial disease. Am J Cardiol. 1966;18:855–8.

    CAS  Article  Google Scholar 

  10. Kato H, Ishida J, Imagawa S, Saito T, Suzuki N, Matsuoka T, et al. Enhanced erythropoiesis mediated by activation of the renin-angiotensin system via angiotensin II type 1a receptor. FASEB J. 2005;19:2023–5.

    CAS  Article  Google Scholar 

  11. Vlahakos DV, Kosmas EN, Dimopoulou I, Ikonomou E, Jullien G, Vassilakos P, et al. Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease. Am J Med. 1999;106:158–64.

    CAS  Article  Google Scholar 

  12. Gould AB, Goodman S, DeWolf R, Onesti G, Swartz C. Interrelation of the renin system and erythropoietin in rats. Transl Res. 1980;96:523–34.

    CAS  Google Scholar 

  13. Kato H, Ishida J, Matsusaka T, Ishimaru T, Tanimoto K, Sugiyama F, et al. Erythropoiesis and blood pressure are regulated via AT1 receptor by distinctive pathways. PLoS ONE. 2015;10:e0129484

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  14. Cole J, Ertoy D, Lin H, Sutliff RL, Guyene TT, Capecchi M, et al. Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice. J Clin Invest. 2000;106:1391–8.

    CAS  Article  Google Scholar 

  15. Raptis AE, Bacharaki D, Mazioti M, Marathias KP, Markakis KP, Raptis SA, et al. Anemia due to coadministration of renin-angiotensin-system inhibitors and PPARγ agonists in uncomplicated diabetic patients. Exp Clin Endocrinol Diabetes. 2012l;120:416–9.

    CAS  Article  Google Scholar 

  16. Ishani A, Weinhandl E, Zhao Z, Gilbertson DT, Collins AJ, Yusuf S, et al. Angiotensin converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2005;45:391–9.

    CAS  Article  Google Scholar 

  17. Vlahakos DV, Canzanello VJ, Madaio MP, Madias NE. Enalapril-associated anemia in renal transplant recipients treated for hypertension. Am J Kidney Dis. 1991;17:199–205.

    CAS  Article  Google Scholar 

  18. Vlahakos DV, Marathias KP, Agroyannis B, Madias NE. Posttransplant erythrocytosis. Kidney Int. 2003;63:1187–94.

    Article  Google Scholar 

  19. Vlahakos DV, Marathias KP, Kosmas EN. Losartan reduces hematocrit in patients with chronic obstructive pulmonary disease and secondary erythrocytosis. Ann Intern Med. 2001;134:426–7.

    CAS  Article  Google Scholar 

  20. Plata R, Cornejo A, Arratia C, Anabaya A, Perna A, Dimitrov BD, et al. Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial. Lancet. 2002;359:663–6.

    CAS  Article  Google Scholar 

  21. Vlahakos DV, Balodimos C, Papachristopoulos V, Vassilakos P, Hinari E, Vlachojannis JG. Renin-angiotensin system stimulates erythropoietin secretion in chronic hemodialysis patients. Clin Nephrol 1995;43:53–9.

    CAS  PubMed  Google Scholar 

  22. Gossmann J, Burkhardt R, Harder S, Lenz T, Sedlmeyer A, Klinkhardt U, et al. Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway. Kidney Int 2001;60:83–6.

    CAS  Article  Google Scholar 

  23. Mrug M, Stopka T, Julian BA, Prchal JF, Prchal JT. Angiotensin II stimulates proliferation of normal early erythroid progenitors. J Clin Invest. 1997;100:2310–4.

    CAS  Article  Google Scholar 

  24. Smith JK Gaisbock’s syndrome: a case study. Clin Med Rev Case Rep. 4:175.

  25. Cheungpasitporn W, Thongprayoon C, Chiasakul T, Korpaisarn S, Erickson SB. Renin-angiotensin system inhibitors linked to anemia: a systematic review and meta-analysis. QJM. 2015;108:879–84.

    CAS  Article  Google Scholar 

  26. Dunlay SM, Weston SA, Redfield MM, Killian JM, Roger VL. Anemia and heart failure: a community study. Am J Med. 2008;121:726–32.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations



DV: drafted the first draft of the manuscript. KM and VV: contributed to the first and second draft of the manuscript and VP performed critical review and critical revisions of the manuscript.

Corresponding author

Correspondence to Vasilios Papademetriou.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Vlahakos, D., Marathias, K., Vlahakos, V. et al. Polycythemia hypertonica revisited: a metabolic syndrome with high-renin hypertension?. J Hum Hypertens 36, 585–587 (2022).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


Quick links